Get early access! Join the Twelve Data AI Assistant waitlist now.

1VT

21.67500 EUR
1.315
5.72%
Last update Sep 8, 7:37 PM CEST
Main market
Day range
21.67500
22.97500
Previous close
22.99000
Open
22.97000
Access this stock data via API
Subscribe
Viking Therapeutics Inc.
21.68
1.32
5.72%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 86.7M 63.8M 54.2M 45.0M
Selling general and admin 42.0M 37.0M 16.1M 10.7M
Other operating expenses
Operating income -128.7M -100.8M -70.4M -55.7M
Non operating interest income
Income 34.9M 15.0M 1.6M 703K
Expense
Other income expense 95.5K -42K 7K
Pretax income -93.8M -85.9M -68.9M -55.0M
Tax provision
Net income -93.8M -85.9M -68.9M -55.0M
Basic EPS -1.0 -0.9 -0.9 -0.7
Diluted EPS -1.0 -0.9 -0.9 -0.7
Basic average shares 93.0M 98.9M 80.0M 80.3M
Diluted average shares 93.0M 98.9M 80.0M 80.3M
EBITDA -128.5M -100.5M -70.0M -55.4M
Net income from continuing op. -93.8M -85.9M -68.9M -55.0M
Minority interests
Preferred stock dividends
Main market

Exchange is currently active.
Closing in 8 hours 28 minutes

11:31
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CEST, UTC+02:00).